The role of proprotein convertase subtilisin/kexin type-9 concentration and paraoxonase 1 activities in the blood of women with polycystic ovary syndrome

Environ Toxicol Pharmacol. 2021 May:84:103612. doi: 10.1016/j.etap.2021.103612. Epub 2021 Feb 8.

Abstract

This study aimed to evaluate the concentration of proprotein convertase subtilisin/kexin type-9 (PCSK9) and the activities of paraoxonase 1 in women with and without polycystic ovary syndrome (PCOS). We found significant higher PCSK9, whereas lower high-density lipoprotein concentration in the serum of women with PCOS when compared to the group without PCOS. Also paraoxonase 1 activities were significantly different between women with PCOS than without PCOS. In addition, the women with PCOS and insulin resistance had higher concentrations of PCSK9 than women with PCOS and insulin sensitivity. Higher PCSK9 concentration in the group with PCOS could be also associated with hormones concentrations. Changes in paraoxonase 1 activities and lipid profile parameters as well as higher concentration of PCSK9 in the group of women with PCOS could be associated with metabolism disorders, but due to the small clinical sample size, the study should be continued.

Keywords: Lipid profile; Paraoxonase; Polycystic ovary syndrome; Proprotein convertase subtilisin/kexin type-9.

MeSH terms

  • Adult
  • Aryldialkylphosphatase / blood*
  • Female
  • Humans
  • Insulin Resistance
  • Lipoproteins, HDL / blood
  • Polycystic Ovary Syndrome / blood*
  • Proprotein Convertase 9 / blood*
  • Young Adult

Substances

  • Lipoproteins, HDL
  • Aryldialkylphosphatase
  • PON1 protein, human
  • PCSK9 protein, human
  • Proprotein Convertase 9